THI20 Antibody

What is THI20 and why is it scientifically significant?

THI20 is a remarkable trifunctional enzyme found in Saccharomyces cerevisiae (baker's yeast) that plays crucial roles in both thiamin biosynthesis and degradation pathways. Its significance stems from its unique fusion protein structure, with its N-terminus showing significant sequence homology to Bacillus subtilis ThiD and its C-terminus homologous to B. subtilis TenA . This trifunctional nature makes THI20 particularly interesting for studying protein evolution and multifunctional enzyme mechanisms. The protein exhibits three distinct enzymatic activities: thiaminase II activity (thiamin degradation), HMP kinase activity, and HMP-P kinase activity (both involved in thiamin biosynthesis) . These multiple functions within a single protein make THI20 an excellent model for studying how organisms evolve efficient metabolic pathways through protein fusion events.

What specific characteristics define THI20 antibodies?

THI20 antibodies are immunological reagents developed to specifically recognize and bind to the THI20 protein (UniProt accession: Q08224) from Saccharomyces cerevisiae . These antibodies are typically generated against specific epitopes within the THI20 protein structure and are characterized by their specificity, sensitivity, and ability to recognize the native protein in various experimental contexts. High-quality THI20 antibodies should demonstrate minimal cross-reactivity with other proteins while maintaining strong affinity for their target across multiple experimental conditions. The specificity of these antibodies is particularly important given THI20's structural similarities to other proteins involved in thiamin metabolism, requiring careful validation to ensure experimental reliability.

How do researchers distinguish between the different functional domains of THI20 when using antibodies?

Distinguishing between THI20's functional domains requires strategic antibody selection and experimental design. Researchers can employ domain-specific antibodies that target either the N-terminal ThiD-like domain or the C-terminal TenA-like domain. This approach requires careful epitope mapping to ensure antibodies recognize specific regions without cross-reactivity. For comprehensive domain analysis, researchers should implement multiple detection methods:

• Use domain-specific antibodies in parallel experiments

• Complement antibody studies with recombinant domain-specific proteins as controls

• Design experiments that can differentiate between the protein's multiple enzymatic activities

When interpreting results, researchers should consider that conformational changes may affect epitope accessibility differently across the protein's functional states. Computational structural analysis of THI20 can help predict which epitopes might be surface-exposed in different conformational states, guiding antibody selection for domain-specific studies.

What are the optimal conditions for Western blotting with THI20 antibodies?

Optimizing Western blot conditions for THI20 antibody applications requires attention to several critical parameters. Based on the trifunctional nature of THI20 and its yeast origin, the following protocol modifications are recommended:

• Sample preparation: For yeast samples, use glass bead lysis in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 10% glycerol, with protease inhibitors. Include 1 mM DTT to preserve protein structure since THI20 may contain functionally important cysteine residues.

• Gel conditions: Use 10-12% SDS-PAGE gels, as THI20 has a molecular weight of approximately 52 kDa. Run the gel at a lower voltage (80-100V) to ensure better resolution.

• Transfer parameters: Semi-dry transfer at 15V for 45 minutes or wet transfer at 30V overnight at 4°C in transfer buffer containing 10% methanol. The latter is particularly important if THI20's hydrophobic domains affect transfer efficiency.

• Blocking conditions: Block with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature. For phospho-specific detection (if studying THI20 regulation), 5% BSA in TBST is preferred.

• Antibody incubation: Dilute primary THI20 antibody to 1:1000-1:2000 in blocking buffer and incubate overnight at 4°C with gentle shaking. After washing, incubate with HRP-conjugated secondary antibody at 1:5000-1:10000 for 1 hour at room temperature.

• Detection: Enhanced chemiluminescence is typically sufficient, but for low abundance detection, consider signal amplification systems.

These conditions should be further optimized based on specific experimental requirements and the particular THI20 antibody used, as different antibody clones may require different conditions for optimal performance.

How can researchers validate THI20 antibody specificity for experimental reliability?

Validating THI20 antibody specificity is essential for research reproducibility and aligns with recent recommendations addressing the "antibody characterization crisis" in scientific literature . A comprehensive validation approach should include:

• Genetic validation: Compare signals between wild-type yeast strains and THI20 deletion mutants. The antibody should show a clear signal in wild-type samples and absence of signal in knockout samples.

• Recombinant protein controls: Use purified recombinant THI20 protein as a positive control, ideally alongside related proteins (like THI21 and THI22 in yeast) to assess cross-reactivity.

• Competitive binding assays: Pre-incubate the antibody with purified THI20 protein before application in your experiment. This should abolish specific signals if the antibody is truly specific.

• Mass spectrometry validation: Perform immunoprecipitation with the THI20 antibody followed by mass spectrometry to confirm that THI20 is indeed the predominant protein being pulled down.

• Multi-technique confirmation: Validate findings across multiple techniques (Western blot, immunoprecipitation, immunofluorescence) to ensure consistent specificity across applications.

• Antibody dilution series: Perform serial dilutions of the antibody to determine the optimal concentration that maximizes specific signal while minimizing background.

Documentation of these validation steps should be maintained in laboratory records and reported in publications to enhance experimental reproducibility and address the concerns raised about antibody reliability in scientific research .

What experimental controls are essential when using THI20 antibodies?

Implementing appropriate controls is critical for generating reliable data with THI20 antibodies, especially given the concerns about antibody specificity in the broader research community . Essential controls include:

• Negative biological controls:

  • THI20 deletion strains (thi20Δ)

  • Related yeast species lacking THI20 homologs

  • Samples where THI20 expression is known to be minimal

• Positive biological controls:

  • Strains overexpressing THI20

  • Samples from conditions known to upregulate THI20 (e.g., thiamine depletion)

  • Purified recombinant THI20 protein

• Technical controls:

  • Secondary antibody-only control to assess non-specific binding

  • Isotype control antibody to identify Fc receptor-mediated binding

  • Pre-immune serum control for polyclonal antibodies

  • Loading controls appropriate for yeast studies (e.g., PGK1, ACT1)

• Validation controls:

  • Peptide competition assay using the immunizing peptide

  • Orthogonal detection methods (e.g., mass spectrometry)

  • Multiple antibodies targeting different epitopes of THI20

How can THI20 antibodies be used to study thiamin biosynthesis pathways in yeast?

THI20 antibodies offer powerful tools for investigating thiamin biosynthesis pathways in yeast through multiple methodological approaches:

• Protein expression profiling: Monitor THI20 protein levels under different nutritional conditions (thiamin-replete vs. thiamin-depleted media) using quantitative Western blotting. This approach reveals how yeast regulates this trifunctional enzyme in response to thiamin availability.

• Co-immunoprecipitation studies: Use THI20 antibodies to pull down protein complexes, identifying interaction partners involved in thiamin metabolism. This technique has revealed previously unknown protein interactions in metabolic pathways and can uncover how THI20 coordinates with other enzymes.

• Subcellular localization: Employ immunofluorescence microscopy with THI20 antibodies to determine the protein's subcellular distribution under different metabolic states. This approach can reveal whether THI20's localization changes in response to thiamin availability.

• Enzymatic activity correlation: Combine THI20 antibody detection with enzymatic activity assays to correlate protein levels with functional outputs of thiaminase II, HMP kinase, and HMP-P kinase activities . This multi-parameter approach provides insight into post-translational regulatory mechanisms.

• Chromatin immunoprecipitation (ChIP): If using tagged versions of transcription factors known to regulate THI20, researchers can correlate transcription factor binding with THI20 protein expression levels using THI20 antibodies.

By integrating these approaches, researchers can develop comprehensive models of how yeast cells regulate thiamin biosynthesis through the multifunctional THI20 protein, providing insights into metabolic pathway integration and enzyme evolution.

What techniques can enhance detection sensitivity when working with low-abundance THI20?

When investigating THI20 under conditions where it may be expressed at low levels, several advanced techniques can enhance detection sensitivity:

• Signal amplification systems: Implement tyramide signal amplification (TSA) for immunohistochemistry or Western blots, which can increase sensitivity by 10-100 fold compared to conventional detection methods.

• Proximity ligation assay (PLA): This technique allows visualization of individual protein molecules through antibody-oligonucleotide conjugates, enabling detection of THI20 at extremely low copy numbers (~10-50 molecules per cell).

• Sample enrichment strategies:

  • Implement subcellular fractionation to concentrate compartments where THI20 is localized

  • Use immunoprecipitation to concentrate THI20 before analysis

  • Apply metabolic labeling techniques (e.g., BONCAT) to selectively detect newly synthesized THI20

• Advanced microscopy techniques:

  • Super-resolution microscopy methods (STED, PALM, STORM) can improve detection of sparse THI20 molecules

  • Single-molecule fluorescence in situ hybridization (smFISH) can be combined with immunofluorescence to correlate THI20 mRNA and protein levels

• Mass spectrometry enhancement:

  • Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) for targeted detection of THI20 peptides

  • Implement chemical crosslinking before immunoprecipitation to stabilize transient interactions

For quantitative applications with low-abundance THI20, digital PCR methodologies for protein (Immuno-dPCR) provide absolute quantification capabilities with detection limits in the femtomolar range, far exceeding traditional Western blot sensitivity.

How does THI20's trifunctional nature affect antibody epitope selection and experimental design?

The trifunctional nature of THI20, with distinct N-terminal ThiD-like and C-terminal TenA-like domains , creates unique considerations for antibody epitope selection and experimental design:

• Domain-specific targeting strategy: Researchers should consider whether their scientific question requires targeting a specific functional domain or the entire protein. For investigating thiaminase II activity, antibodies targeting the C-terminal TenA-like domain are more relevant, while HMP/HMP-P kinase studies benefit from N-terminal domain targeting.

• Conformational state considerations: THI20's multiple enzymatic activities likely involve conformational changes that may mask or expose different epitopes. Researchers must consider whether their antibodies recognize native conformations, denatured states, or both.

• Epitope interference with substrate binding: Antibodies targeting regions near enzyme active sites may interfere with substrate binding or catalysis. This property can be exploited to study enzyme mechanism but must be considered when interpreting activity assays performed in the presence of antibodies.

• Cross-reactivity with homologous proteins: S. cerevisiae contains two THI20 paralogs (THI21 and THI22) with high sequence similarity. Epitope selection must account for unique regions to avoid cross-reactivity, particularly when studying differential regulation of these related proteins.

• Post-translational modification awareness: If THI20 undergoes regulatory modifications (phosphorylation, acetylation, etc.), epitope selection should avoid these sites unless the research specifically targets modified forms.

Experimental design should include appropriate controls for each of these considerations, such as using multiple antibodies targeting different domains, comparing results in native vs. denaturing conditions, and validating specificity against purified THI21 and THI22 proteins.

What are common pitfalls when interpreting THI20 antibody results and how can they be avoided?

Interpreting results from THI20 antibody experiments presents several challenges that researchers should actively address:

• Misinterpreting paralog signals: THI20 shares high sequence similarity with its paralogs THI21 and THI22 in S. cerevisiae, potentially leading to cross-reactivity. To avoid this pitfall:

  • Use genetic controls (thi20Δ, thi21Δ, thi22Δ, and combination mutants)

  • Verify results with multiple antibodies targeting different epitopes

  • Validate antibody specificity using recombinant proteins

• Overlooking post-translational modifications: THI20 may undergo modifications that affect antibody recognition. Researchers should:

  • Use phosphorylation-state specific antibodies when studying THI20 regulation

  • Compare results from multiple antibodies recognizing different epitopes

  • Consider enriching modified forms using phospho-affinity chromatography before immunodetection

• Misattributing enzymatic activity: THI20's trifunctional nature means observed phenotypes could result from any of its three activities. Researchers should:

  • Design domain-specific mutations to differentiate between functions

  • Complement antibody studies with activity assays for each function

  • Use domain-specific antibodies to correlate specific structures with functions

• Background signal misinterpretation: Non-specific binding can lead to false positives. To address this:

  • Always include knockout controls

  • Implement peptide competition assays

  • Use gradient antibody dilutions to distinguish specific from non-specific signals

• Neglecting cellular context: THI20 expression and localization may vary with growth conditions and cell cycle. Researchers should:

  • Standardize growth conditions when comparing samples

  • Include time-course analyses when relevant

  • Consider single-cell analyses to account for population heterogeneity

By systematically addressing these potential pitfalls, researchers can increase confidence in their THI20 antibody-based findings and contribute to the reproducibility of yeast metabolism research.

How should researchers troubleshoot inconsistent results with THI20 antibodies?

When faced with inconsistent results using THI20 antibodies, researchers should implement a systematic troubleshooting approach:

• Antibody quality assessment:

  • Check antibody age, storage conditions, and freeze-thaw cycles

  • Validate antibody performance with positive controls (recombinant THI20)

  • Consider testing a new lot or a different antibody targeting the same protein

• Sample preparation evaluation:

  • Ensure complete protease inhibition during extraction

  • Verify protein integrity by silver staining or Coomassie blue staining

  • Test different lysis methods (chemical vs. mechanical) for optimal extraction

  • Implement fresh sample preparation to eliminate degradation issues

• Technical parameter optimization:

  • Systematically vary antibody concentration, incubation time, and temperature

  • Test different blocking agents (milk vs. BSA vs. commercial blockers)

  • Adjust washing stringency and duration

  • Optimize detection method sensitivity based on expected abundance

• Experimental design refinement:

  • Incorporate additional positive and negative controls

  • Include internal reference proteins for normalization

  • Test reproducibility across biological replicates

  • Verify key findings with orthogonal methods

• Documentation and standardization:

  • Create detailed protocols recording all parameters

  • Maintain a troubleshooting log documenting variations tested

  • Standardize critical reagents and protocols once optimized

  • Consider antibody validation practices recommended in recent literature

Through systematic implementation of these troubleshooting approaches, researchers can identify sources of inconsistency and develop robust, reproducible protocols for THI20 antibody applications.

How can quantitative analysis of THI20 expression be reliably performed?

Reliable quantitative analysis of THI20 expression requires rigorous methodological approaches to ensure accuracy and reproducibility:

• Western blot quantification best practices:

  • Use a standard curve of recombinant THI20 protein for absolute quantification

  • Ensure signal linearity by testing multiple sample dilutions

  • Employ digital image acquisition with appropriate exposure settings to avoid saturation

  • Use total protein normalization (REVERT or similar stains) rather than single housekeeping proteins

  • Apply appropriate statistical analysis across multiple biological replicates

• Advanced quantitative techniques:

  • Implement ELISA or other immunoassay formats calibrated with recombinant standards

  • Consider mass spectrometry-based quantification using isotope-labeled peptide standards

  • Apply Single-cell Western techniques for population heterogeneity analysis

  • Utilize quantitative immunofluorescence with careful calibration

• Normalization strategies:

  • Normalize to total protein concentration determined by Bradford or BCA assays

  • For yeast-specific applications, normalize to cell number or optical density

  • Consider dual normalization strategies combining multiple approaches

  • Account for differences in extraction efficiency between samples

• Data analysis framework:

  • Apply appropriate statistical methods for the experimental design

  • Use non-parametric tests when assumptions of normality cannot be met

  • Account for technical and biological variability in uncertainty estimates

  • Consider Bayesian approaches for small sample sizes

• Reporting standards:

  • Clearly document all quantification methods and parameters

  • Report both raw and normalized data

  • Include measures of variability (standard deviation, confidence intervals)

  • Make image analysis workflows available for reproducibility

By applying these rigorous approaches to THI20 quantification, researchers can generate reliable data on expression levels under different conditions, enabling meaningful comparisons across experiments and between laboratories.

How can custom-designed THI20 antibodies advance research on thiamin metabolism?

Custom-designed THI20 antibodies offer powerful opportunities to advance thiamin metabolism research through targeted approaches:

• Domain-specific antibodies: Developing antibodies that specifically recognize the ThiD-like (N-terminal) or TenA-like (C-terminal) domains of THI20 can help dissect the protein's multiple functions. This approach enables researchers to:

  • Track conformational changes associated with different enzymatic activities

  • Identify conditions that selectively activate specific functions

  • Study domain-specific protein-protein interactions

• Modification-specific antibodies: Custom antibodies recognizing post-translational modifications of THI20 can reveal regulatory mechanisms:

  • Phospho-specific antibodies can track activation/inactivation cycles

  • Antibodies targeting other modifications (acetylation, ubiquitination) can reveal additional regulatory layers

  • These tools enable temporal tracking of THI20 regulation in response to metabolic changes

• Engineered antibody fragments: Developing smaller antibody formats (Fabs, scFvs, nanobodies) with THI20 specificity provides:

  • Better penetration in live-cell imaging applications

  • Reduced interference with protein function in mechanistic studies

  • Potential for intracellular expression to track or perturb THI20 in living cells

• Antibody-based biosensors: Coupling THI20 antibodies with fluorescent reporters creates tools to:

  • Monitor real-time changes in THI20 conformation or modification state

  • Track THI20 localization in living cells

  • Detect interactions with metabolites or protein partners

• Therapeutic exploration: Though primarily a research tool, engineered THI20 antibodies could potentially:

  • Serve as probes for studying pathogenic fungi that rely on similar thiamin metabolism pathways

  • Provide templates for developing inhibitors of fungal thiamin metabolism

These custom antibody approaches align with the broader trend in antibody technology development where more specific, engineered antibody formats are enhancing research capabilities across biological disciplines .

What experimental approaches can differentiate between THI20's multiple enzymatic activities?

Differentiating between THI20's three enzymatic activities—thiaminase II, HMP kinase, and HMP-P kinase —requires sophisticated experimental designs:

• Domain-selective inhibition studies:

  • Use domain-specific antibodies to selectively inhibit one functional domain

  • Apply computational design to develop domain-selective small molecule inhibitors

  • Generate point mutations that selectively disrupt individual active sites while preserving protein stability

• Activity-specific assay systems:

  • For thiaminase II activity: Measure thiamin degradation using HPLC or LC-MS/MS

  • For HMP kinase activity: Quantify ATP consumption or HMP-P formation

  • For HMP-P kinase activity: Detect HMP-PP production

  • Implement these assays in parallel with the same protein preparation

• Structural biology approaches:

  • Use cryo-EM to capture THI20 in different conformational states

  • Apply hydrogen-deuterium exchange mass spectrometry to track conformational dynamics

  • Develop FRET-based sensors to monitor domain movements associated with specific activities

• Genetic complementation strategies:

  • Express individual domains in strains lacking full THI20

  • Complement with orthologous proteins having single activities

  • Create chimeric proteins with domains from related enzymes

• Substrate competition analysis:

  • Perform enzyme kinetics with mixed substrates to identify preferential activity

  • Use isotope-labeled substrates to track flux through different reaction pathways

  • Apply metabolic flux analysis to determine the relative contribution of each activity in vivo

These methodologies, especially when applied in combination, can provide a comprehensive understanding of how THI20's multiple enzymatic activities are coordinated and regulated, offering insights into the evolution and functional integration of multifunctional enzymes.

How can researchers leverage THI20 antibody technology for comparative studies across fungal species?

Leveraging THI20 antibody technology for comparative fungal studies requires strategic approaches to address cross-species variation while maintaining detection specificity:

• Epitope conservation analysis:

  • Perform sequence alignment of THI20 homologs across fungal species

  • Identify highly conserved regions suitable for broad-specificity antibodies

  • Design species-specific antibodies targeting divergent regions for comparative studies

• Cross-species validation methodology:

  • Test antibody recognition using recombinant THI20 proteins from different species

  • Implement Western blots with samples from multiple species run in parallel

  • Validate with genetic knockouts in each species where possible

• Comparative expression profiling:

  • Apply validated antibodies to study expression patterns across evolutionarily related fungi

  • Compare THI20 regulation in pathogenic versus non-pathogenic fungi

  • Correlate expression with species-specific metabolic adaptations

• Evolutionary studies applications:

  • Map functional domain conservation using domain-specific antibodies

  • Track evolutionary acquisition of multifunctionality in the thiamin pathway

  • Correlate structural variations with enzymatic function differences

• Practical implementation:

  • Standardize sample preparation protocols across species

  • Adjust antibody concentrations to account for binding affinity differences

  • Implement quantitative normalization strategies appropriate for cross-species comparisons

This table provides researchers with practical guidance for applying THI20 antibodies across fungal species, facilitating comparative studies while accounting for evolutionary divergence in protein sequence and structure.

What are the current best practices for THI20 antibody validation in line with reproducibility initiatives?

Current best practices for THI20 antibody validation align with broader reproducibility initiatives in antibody research and include comprehensive validation strategies:

• Multi-level validation approach:

  • Genetic validation using knockout strains (thi20Δ)

  • Recombinant protein validation with both target and related proteins (THI21, THI22)

  • Application-specific validation for each technique (Western blot, IP, IF, etc.)

  • Cross-laboratory validation when possible to ensure reproducibility

• Comprehensive documentation:

  • Record detailed validation protocols and results

  • Document antibody source, lot number, and storage conditions

  • Maintain validation data in accessible laboratory records

  • Include validation methods and results in publications

• Standardized reporting:

  • Follow field-specific guidelines for antibody reporting in publications

  • Include all validation controls in supplementary materials

  • Provide detailed methods sections describing validation

  • Deposit validation data in public repositories when available

• Ongoing validation:

  • Periodically revalidate antibodies, especially with new lots

  • Extend validation as new applications are developed

  • Update validation when moving to different biological systems

  • Validate against new controls as they become available

• Community engagement:

  • Share validation protocols and data with other researchers

  • Participate in collaborative validation initiatives

  • Report validation problems to antibody suppliers

  • Contribute to community standards development

These practices not only enhance the reliability of THI20 antibody research but also contribute to addressing the broader "antibody characterization crisis" identified in the scientific literature , ultimately improving research reproducibility and accelerating scientific progress in fungal metabolism studies.

How should researchers integrate emerging antibody technologies into THI20 research?

Researchers should adopt a strategic approach to integrating emerging antibody technologies into THI20 research that balances innovation with methodological rigor:

• Recombinant antibody adoption:

  • Consider transitioning from polyclonal to recombinant monoclonal antibodies for THI20 detection

  • Evaluate recombinant antibody formats (scFvs, Fabs, nanobodies) for specific applications

  • Implement sequence-defined antibodies that allow exact reproduction across studies

  • Compare performance against traditional antibodies before complete transition

• Advanced detection integration:

  • Explore proximity-based detection methods (PLA, BRET, FRET) for studying THI20 interactions

  • Adopt single-molecule detection technologies for low-abundance analysis

  • Implement multiplexed antibody approaches to simultaneously track THI20 alongside interaction partners

  • Develop live-cell compatible antibody formats for dynamic studies

• Computational enhancement:

  • Utilize structure-based antibody design to target specific THI20 epitopes

  • Apply machine learning algorithms to optimize antibody selection for specific applications

  • Implement digital image analysis pipelines for quantitative antibody-based detection

  • Develop predictive models for antibody performance across experimental conditions

• Validation framework adaptation:

  • Establish validation protocols specifically designed for new antibody formats

  • Develop quantitative metrics for comparing traditional and emerging antibody technologies

  • Create benchmark datasets for validating new THI20 antibody applications

  • Implement automated validation workflows when possible

• Implementation roadmap:

  • Establish parallel testing periods when introducing new technologies

  • Develop clear criteria for technology adoption decisions

  • Create standardized training protocols for new methodologies

  • Maintain continuous validation as technologies evolve

By following this structured approach, researchers can effectively harness emerging antibody technologies to advance THI20 research while maintaining scientific rigor and ensuring data comparability across studies and laboratories.

What future research directions might THI20 antibodies enable in fungal metabolism studies?

THI20 antibodies are poised to enable several promising research directions in fungal metabolism studies:

• Systems-level integration of thiamin metabolism:

  • Multi-omics approaches combining THI20 antibody-based proteomics with metabolomics

  • Network analysis of THI20 interactions under varying metabolic states

  • Spatial mapping of thiamin biosynthesis complexes using super-resolution microscopy

  • Development of mathematical models incorporating THI20's multiple enzymatic activities

• Evolutionary adaptation mechanisms:

  • Comparative studies of THI20 regulation across evolutionarily distant fungi

  • Investigation of domain specialization in species with multiple THI20 paralogs

  • Analysis of THI20 function in extremophile fungi with unique metabolic adaptations

  • Reconstruction of ancestral THI20 proteins to study functional evolution

• Biotechnological applications:

  • Engineering THI20 variants with enhanced or modified enzymatic properties

  • Development of fungal strains with optimized thiamin production for industrial applications

  • Creation of biosensors based on THI20 antibodies for metabolic engineering

  • Exploration of THI20 as a potential antifungal target in pathogenic species

• Fundamental enzyme mechanism studies:

  • Investigation of how THI20 coordinates its multiple catalytic activities

  • Analysis of conformational changes associated with substrate binding and catalysis

  • Elucidation of regulatory mechanisms controlling THI20's functional balance

  • Detailed structural studies of domain interactions within the multifunctional enzyme

• Translational research connections:

  • Comparative analysis of fungal thiamin metabolism with human thiamin processing

  • Investigation of THI20-like enzymes in fungal pathogens as potential drug targets

  • Development of model systems for studying human thiamin metabolism disorders

  • Exploration of biotechnological applications in vitamin production